News - Patents

Filter

Current filters:

Patents

Popular Filters

54 to 78 of 432 results

Biogen prevails in EU exclusivity battle for MS drug Tecfidera

Biogen prevails in EU exclusivity battle for MS drug Tecfidera

25-11-2013

US biotech company Biogen Idec saw its shares leap 10% to an all-time high of nearly $278 on Friday,…

Biogen IdecBiotechnologyEuropeNeurologicalPatentsRegulationTecfidera

I-MAK challenges Gilead sofosbuvir patent in India

I-MAK challenges Gilead sofosbuvir patent in India

25-11-2013

USA-based advocacy group the Initiative for Medicines, Access & Knowledge last week filed a challenge…

Anti-viralsAsia-PacificBiotechnologyGilead SciencesPatentssofosbuvirSovaldi

Cadence Pharma leaps on positive patent litigation ruling

17-11-2013

The US District Court for the District of Delaware has ruled in favor of Cadence Pharmaceuticals in the…

Cadence PharmaceuticalsGenericsLegalNeurologicalNorth AmericaOfirmevPatents

Actavis confirms challenge of Lilly’s Axiron patent

Actavis confirms challenge of Lilly’s Axiron patent

14-11-2013

US generics major Actavis confirms that it has filed an Abbreviated New Drug Application with the US…

ActavisAxironEli LillyGenericsLegalMen's HealthNorth AmericaPatentsRegulation

Forest Labs settles Bystolic litigation with Actavis

07-11-2013

US drugmaker Forest Laboratories has entered into a settlement agreement with generics drug major Actavis…

ActavisBystolicCardio-vascularForest LaboratoriesGenericsLegalNorth AmericaPatents

US FTC finalizes amendments to the premerger notification rules on patent right transfers

07-11-2013

The US Federal Trade Commission yesterday (November 6) issued final changes to the premerger notification…

LegalMergers & AcquisitionsNorth AmericaPatentsPharmaceutical

South Africa sets out intellectual property policy, with focus on public health

06-11-2013

South Africa’s government’s policy on intellectual property (IP), which is currently under discussion,…

HealthcarePatentsPharmaceuticalPoliticsRest of the WorldSouth Africa

Sandoz appeals US court decision on AzaSite patent

Sandoz appeals US court decision on AzaSite patent

06-11-2013

US ophthalmic care specialist InSite Vision says that Sandoz Inc, the US generics unit of Swiss drug…

AzaSiteGenericsInSite VisionLegalNorth AmericaNovartisOphthalmicsPatentsSandoz

Canadian government concludes CETA, which is welcomed by Rx&D

25-10-2013

Canada’s Research-Based Pharmaceutical Companies (Rx&D) association applauds the government of Canada’s…

EuropeNorth AmericaPatentsPharmaceuticalPoliticsResearch

Health activists in South Africa urge govt to “stop blindly handing out” pharma patents

Health activists in South Africa urge govt to “stop blindly handing out” pharma patents

18-10-2013

Marching in Pretoria yesterday in support of government-proposed patent law reforms, Medicines Sans Frontieres,…

HealthcarePatentsPharmaceuticalPoliticsRest of the WorldSouth Africa

BIA UK BioScience Forum: The benefits of the European Unitary Patent

BIA UK BioScience Forum: The benefits of the European Unitary Patent

14-10-2013

Updates on Intellectual Property developments in Europe were heard by delegates at the BIA UK BioScience…

EuropeInterviewsPatentsPharmaceutical

TAC views “pharma myths” around South Africa’s patent law reform

11-10-2013

As the Fix the Patent Laws campaign gains traction and South Africa moves closer towards the kind of…

PatentsPharmaceuticalPoliticsRest of the WorldSouth Africa

Acura Pharma settles with Par and Impax over Oxecta

Acura Pharma settles with Par and Impax over Oxecta

11-10-2013

US specialty pharma firm Acura Pharmaceuticals saw its shares leap as much as 28% after it said that…

Acura PharmaceuticalsGenericsImpax LaboratoriesLicensingNeurologicalNorth AmericaOxectaPar PharmaceuticalPatents

Actavis confirms generic Suboxone sublingual film patent challenge

Actavis confirms generic Suboxone sublingual film patent challenge

09-10-2013

Actavis has filed an Abbreviated New Drug Application with the US Food and Drug Administration for buprenorphine…

ActavisGenericsNeurologicalNorth AmericaPatentsReckitt BenckiserSuboxone

Teva gets favorable Copaxone patent ruling in Netherlands

Teva gets favorable Copaxone patent ruling in Netherlands

04-10-2013

The District Court of the Hague has issued a favorable ruling for Teva Pharmaceutical Industries in a…

EuropeGenericsLegalNeurologicalPatentsPharmaceutical

Indian pharmaceutical market to reach $56 billion by 2020, says GlobalData

03-10-2013

Driven by the country’s growing economy and population income, the Indian pharmaceutical market will…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalRegulation

AusBiotech joins forces with Cook Medical and Deloitte on tax

27-09-2013

Australian biotechnology industry experts are joining forces to support a “patent box” tax incentive,…

Asia-PacificBiotechnologyFinancialPatentsResearch

Plasma Tech claims patent for its product will shake up plasma biopharma market

11-09-2013

Privately-held US firm Plasma Technologies announced the recent issuance of US patent No 8,293,242, an…

BiotechnologyPatentsPlasma Technologies

New policy aims to increase pharma competition and lower drug prices in South Africa

10-09-2013

The South African Department of Trade and Industry (DTI) has called for public comment on the draft National…

PatentsPharmaceuticalRest of the World

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Pharmaceutical patent sale of first-in-class compounds to treat women's health needs

31-08-2013

IP Shakti, an early-stage seed fund for biomedical and life science innovations and the exclusive broker…

BezielleIP ShaktiLicensingMenerbaPatentsPharmaceuticalSealaWomen's Health

Imprimis acquires IP rights to ophthalmic compound

30-08-2013

USA-based Imprimis Pharmaceuticals (Nasdaq: IMMY), which is focused on the commercialization of drug…

Imprimis PharmaceuticalsIPI-140OphthalmicsPatentsPharmaceutical

54 to 78 of 432 results

Back to top